Cargando…
Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine
BACKGROUND: The United States Food and Drug Administration (FDA) monitors, inspects, and enforces the promotion of products by companies that claim to mitigate, prevent, treat, diagnose, or cure COVID-19. The introduction of COVID-19-related diagnostics and therapeutics during the pandemic has highl...
Autores principales: | Tran, Allan, Sheikhan, Natasha Y., Sheikhan, Tania, Nowak, Dominik A., Witek, Theodore J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651501/ https://www.ncbi.nlm.nih.gov/pubmed/34876238 http://dx.doi.org/10.1186/s42238-021-00109-6 |
Ejemplares similares
-
Unsubstantiated Claims Can Lead to Tragic Conservation Outcomes
por: Rojas-Bracho, Lorenzo, et al.
Publicado: (2019) -
Chiropractic students call for action against unsubstantiated claims
por: Plener, Joshua, et al.
Publicado: (2020) -
Public Health Concerns and Unsubstantiated Claims at the Intersection of Vaping and COVID-19
por: Majmundar, Anuja, et al.
Publicado: (2020) -
Incorrect statistical method in parallel-groups RCT led to unsubstantiated conclusions
por: Allison, David B., et al.
Publicado: (2016) -
Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms
por: Sheikhan, Natasha Y., et al.
Publicado: (2021)